OSE Immunotherapeutics

Parachute over La Jolla California
Biotech

Metsera sale architect swings to Structure—Chutes & Ladders

Metsera acquisition architect swings to Structure. Vir CMO exits after less than 2 years. Leal reels in Big Pharma vets to exec team.
Parachute over a desert

BioNTech founders to pioneer new company—Chutes & Ladders

Mar 13, 2026 8:30am
two baskets of eggs on a farm

Boehringer axes MASH deal after OSE asset fails to show efficacy

Mar 2, 2026 2:16pm
reshuffle pipeline target reorganize shift change

Ose narrows focus to conserve cash at expense of wider pipeline

Dec 9, 2025 9:41am
A ballpoint pen rests on top of a stack of documents ready for signing

AbbVie hands back phase 1 duties for inflammation drug to Ose

Dec 8, 2025 5:39am
parachute mountains sunset clouds

Former CBER chief Peter Marks leaps to Lilly—Chutes & Ladders

Oct 10, 2025 8:30am